648 filings
S-3
JAGX
Jaguar Health Inc
Shelf registration
22 Apr 24
4:31pm
10-K/A
2023 FY
JAGX
Jaguar Health Inc
Annual report (amended)
17 Apr 24
5:22pm
8-K
JAGX
Jaguar Health Inc
9 Apr 24
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
5:26pm
424B5
JAGX
Jaguar Health Inc
2 Apr 24
Prospectus supplement for primary offering
4:32pm
S-8
JAGX
Jaguar Health Inc
1 Apr 24
Registration of securities for employees
4:31pm
8-K
qo1xg38 2htkwd
21 Mar 24
Agreement terms to include payment of double-digit royalties to Jaguar on all Crofelemer products sold in the licensed territory
4:30pm
8-K
0m11yi1a
8 Mar 24
Unregistered Sales of Equity Securities
5:00pm
8-K
fqx3uk9
1 Mar 24
Entry into a Material Definitive Agreement
5:30pm
8-K
qd08g2vlt5jrv25f6xwc
16 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:13pm
8-K
6ilpi a8tfcnoy4
1 Dec 23
Entry into a Material Definitive Agreement
5:25pm
D
u9dd1
30 Nov 23
$60.00 k in equity / Common Stock, sold $60.00 k, 1 investor
8:10am
8-K
hoegn0tpnnm9qh hf
8 Nov 23
Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq’s Bid Price Rule
5:03pm
8-K
gl2f1 exxdau4
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
S-8
igrfl65n0 57gzq
14 Aug 23
Registration of securities for employees
4:16pm
8-K
tjv6w5pjsin7
14 Aug 23
Jaguar Health Reports Second Quarter 2023 Financial Results
9:05am